Alzheimer’s and Dementia
Alzheimer's and Dementia
Easing the Burden of Alzheimer's
Schaeffer experts from across disciplines are addressing Alzheimer’s disease and related dementias (ADRD) by evaluating its toll, promoting access to earlier diagnoses and treatment, and developing new models for covering the cost of
innovative therapies.
Featured News
Key USC Researchers’ Dementia Cost Model Aims to Help Patients, Families
Knowing the actual costs of dementia could help families plan their budgets and support needs, inform treatment and caregiving options, and shape health care policy.
Experts: Julie Zissimopoulos, Dana Goldman, Bryan Tysinger, Hanke Heun-Johnson, Duncan Ermini Leaf, Johanna Thunell, Geoffrey Joyce, Sze-chuan Suen, Eileen Crimmins, Mireille Jacobson
Latest on Alzheimer's View All
News
U.S. Dementia Costs to Exceed $780 Billion This Year, USC-Led Research Finds
Featured Experts: Julie Zissimopoulos, Dana Goldman, Bryan Tysinger
In The News View All
USC Today
Proposed Medicare coverage of at-home long-term care would have profound impact, Zissimopoulos says
Featured Experts: Julie Zissimopoulos
NPR
Zissimopoulos interviewed on the health and economic benefits of delaying Alzheimer’s
Featured Experts: Julie Zissimopoulos
MedPage Today
Without Early Detection, Fighting Dementia Is an Uphill Battle
Featured Experts: Julie Zissimopoulos
Featured Research
Study Reveals Racial Disparities in Diagnosis and Drug Use for Dementia Symptoms
White and Hispanic people are most likely to be diagnosed with behavioral symptoms of dementia, but they’re also most likely to be treated with potentially harmful drugs, according to a new USC study.
Experts: Johanna Thunell, Julie Zissimopoulos, Geoffrey Joyce
